Monthly Archives: May 2021


The Cells for Life Group is dedicated to supporting preclinical studies and clinical trials in the use of umbilical cord blood in regenerative medicine applications. Dr Malhotra’s Cord SaFe study will review the feasibility and safety of administering autologous cord blood of extreme premature infants (<28 weeks gestation). Vital parameters, examinations and any adverse events… Read more »